• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR SUPERA SELF-EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR SUPERA SELF-EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM Back to Search Results
Model Number S-65-150-120-P6
Device Problems Mechanical Jam (2983); Activation Failure (3270)
Patient Problems Renal Failure (2041); Foreign Body In Patient (2687)
Event Date 01/22/2022
Event Type  Injury  
Event Description
It was reported that the procedure was to treat a 100% stenosed lesion in the right femoral artery.Pre-dilatation was performed.The 6.5x150mm supera self expanding stent system (sess) was advanced, however, the deployment lock did not work and failed to deploy the stent.The patient had renal failure due to amount of contrast medium used and there was unplanned medication and prolonged hospitalization.The patient is controlled and continues with medication.No additional information was provided.
 
Manufacturer Narrative
The device is expected to be returned for investigation.It has not yet been received.A follow-up report will be submitted with all additional relevant information.
 
Manufacturer Narrative
The device was returned for analysis and the tip was identified to be separated and not returned.Follow-up with the site was performed; however, the site was unaware of the tip separation and could not confirm the location of the tip.The reported activation/deployment failure was able to be confirmed.The reported mechanical jam was able to be confirmed.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other incidents from this lot.It is possible that interaction with the 100% stenosed anatomy resulted in the ratchet being unable to properly engage and release the stent from the delivery system; thus resulting in the reported mechanical jam and the reported activation failure/ deployment failure; however this cannot be confirmed.The investigation determined a conclusive cause for the reported mechanical jam and activation/deployment failure cannot be determined.Manipulation of the device likely resulted in the noted device damages (stretched/separated inner member, smashed ratchet braiding, separated tip).The reported patient effect of renal failure is listed in the supera peripheral stent system instructions for use as a potential adverse effect of peripheral percutaneous intervention.A conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.However, the treatment appears to be related to the operational context of the procedure as there was unplanned medication and prolonged hospitalization.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Event Description
It was reported that the procedure was to treat a 100% stenosed lesion in the right femoral artery.Pre-dilatation was performed.The 6.5x150mm supera self expanding stent system (sess) was advanced, however, the deployment lock did not work and failed to deploy the stent.The patient had renal failure due to the amount of contrast medium used and there was unplanned medication and prolonged hospitalization.Subsequent to the initially filed report the following information was provided: the patient is controlled and continues with medication.Returned device analysis identified that there was a tip separation and the separated tip was not returned.The account was not aware of the separation and could not confirm what happened to the separated tip.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUPERA SELF-EXPANDING STENT SYSTEM
Type of Device
SELF EXPANDING PERIPHERAL STENT SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 2024168
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key13938737
MDR Text Key288109734
Report Number2024168-2022-03262
Device Sequence Number1
Product Code NIP
UDI-Device Identifier08717648226328
UDI-Public08717648226328
Combination Product (y/n)N
Reporter Country CodeMX
PMA/PMN Number
P120020
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 07/07/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/29/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/31/2022
Device Model NumberS-65-150-120-P6
Device Catalogue NumberS-65-150-120-P6
Device Lot Number0082461
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/29/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/24/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Age80 YR
Patient SexMale
Patient Weight80 KG
-
-